Table 3

Predictors of 1-year MI or vascular death in 2015–2018 cohort

Predictor variableMI or vascular deathRecurrent stroke
Adjusted*
HR
(95% CI)
P valueAdjusted*
HR
(95% CI)
P value
Age, years1.03 (1.02 to 1.04)<0.0011.01 (1.00 to 1.01)<0.001
Male sex0.89 (0.67 to 1.18)0.4051.06 (0.94 to 1.19)0.381
NIHSS >61.91 (1.46 to 2.49)<0.0011.21 (1.07 to 1.36)0.002
Final diagnosis of stroke2.51 (1.11 to 5.68)0.0282.20 (1.65 to 2.93)<0.001
TOAST Classification
 Cardioembolism0.70 (0.43 to 1.14)0.1510.88 (0.68 to 1.13)0.298
 Non-cardioembolismRef.Ref.Ref.Ref.
Previous stroke/TIA1.69 (1.30 to 2.20)<0.0011.56 (1.40 to 1.75)<0.001
Previous MI1.83 (0.96 to 3.47)0.0660.99 (0.69 to 1.42)0.958
Coronary artery disease1.50 (1.08 to 2.07)0.0151.23 (1.04 to 1.45)0.016
Hypertension0.95 (0.71 to 1.25)0.6951.01 (0.89 to 1.13)0.937
Diabetes mellitus1.15 (0.87 to 1.54)0.3321.17 (1.04 to 1.32)0.008
Atrial fibrillation1.83 (1.20 to 2.80)0.0051.14 (0.90 to 1.45)0.272
Current smoking0.96 (0.70 to 1.31)0.7991.01 (0.89 to 1.15)0.863
Treatment
 Endovascular therapy2.45 (1.13 to 5.33)0.0242.00 (1.21 to 3.29)0.007
 Early antiplatelet0.47 (0.32 to 0.67)<0.0010.70 (0.58 to 0.85)<0.001
 Lipid lowing at discharge0.39 (0.27 to 0.56)<0.0010.70 (0.58 to 0.84)<0.001
 Antihypertension at discharge0.99 (0.74 to 1.31)0.9221.05 (0.93 to 1.17)0.441
  • *Adjusted for sex, age, NIHSS >6, history of Previous stroke/TIA, previous MI, known coronary artery disease, hypertension, diabetes mellitus, atrial fibrillation, peripheral artery disease, current smoker and lipid lowering and antihypertensive treatments.

  • MI, myocardial infarction; NIHSS, National Institutes of Health Stroke Scale; TIA, transient ischaemic attack; TOAST, Trial of Org 10 712 in acute stroke treatment.